JHYI99  skapat en ny artikel
10 i ·Översätt

Competitive Landscape and Strategic Analysis of Key Players (Adaptive Biotechnologies, Natera, Guardant Health, and Roche) (2026–2033) | #minimal residual disease market

Competitive Landscape and Strategic Analysis of Key Players (Adaptive Biotechnologies, Natera, Guardant Health, and Roch

Competitive Landscape and Strategic Analysis of Key Players (Adaptive Biotechnologies, Natera, Guardant Health, and Roch

The minimal residual disease market size was valued at USD 2.13 billion in 2024 and is projected to reach USD 3.92 billion by 2032, with a CAGR of 7.90% during the forecast period of 2025 to 2032.